Korea Investment CORP Takes $14.30 Million Position in Nordson Corporation $NDSN

Korea Investment CORP acquired a new position in shares of Nordson Corporation (NASDAQ:NDSN - Free Report) in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 47,388 shares of the industrial products company's stock, valued at approximately $14,296,000. Korea Investment CORP owned 0.09% of Nordson at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in NDSN. Clearstead Trust LLC bought a new position in shares of Nordson in the second quarter worth $25,000. Keating Financial Advisory Services Inc. bought a new stake in shares of Nordson during the second quarter valued at about $30,000. CYBER HORNET ETFs LLC bought a new stake in shares of Nordson during the second quarter valued at about $31,000. N.E.W. Advisory Services LLC acquired a new stake in Nordson in the second quarter worth about $33,000. Finally, MUFG Securities EMEA plc bought a new position in Nordson in the 2nd quarter valued at about $34,000. 72.11% of the stock is currently owned by institutional investors and hedge funds.

Nordson Price Performance

Shares of NASDAQ:NDSN opened at $332.24 on Monday. Nordson Corporation has a 52 week low of $220.06 and a 52 week high of $338.55. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.18 and a current ratio of 1.82. The company has a market cap of $18.51 billion, a PE ratio of 33.59, a price-to-earnings-growth ratio of 2.17 and a beta of 0.96. The firm has a 50 day simple moving average of $298.83 and a 200 day simple moving average of $287.14.

Nordson (NASDAQ:NDSN - Get Free Report) last announced its earnings results on Wednesday, August 19th. The industrial products company reported $3.25 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.09 by $0.16. The company had revenue of $817.67 million for the quarter, compared to the consensus estimate of $779.49 million. Nordson had a net margin of 18.63% and a return on equity of 20.49%. The company's revenue was up 10.3% on a year-over-year basis. During the same period in the previous year, the business earned $2.73 EPS. Nordson has set its FY 2026 guidance at 11.800-12.000 EPS. As a group, research analysts expect that Nordson Corporation will post 11.8 earnings per share for the current year.

Nordson Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, July 6th. Investors of record on Thursday, June 18th were paid a $0.82 dividend. This represents a $3.28 annualized dividend and a yield of 1.0%. The ex-dividend date of this dividend was Thursday, June 18th. Nordson's dividend payout ratio is currently 33.16%.

Nordson News Summary

Here are the key news stories impacting Nordson this week:

• Positive Sentiment: Strong Q3 beat and broad-based growth: Nordson reported adjusted earnings of $3.25 per share, above the $3.09 consensus and up from $2.73 a year earlier. Revenue reached $817.7 million, exceeding estimates of $779.5 million and increasing 10.3% year over year. Record sales across all segments, stronger orders and broad organic growth supported the results. NDSN Q3 Earnings Beat Estimates on Broad Organic Growth
• Positive Sentiment: Higher fiscal 2026 outlook: Management raised its outlook for the third time, forecasting fiscal 2026 sales of $3.035 billion to $3.075 billion and adjusted EPS of $11.80 to $12.00. Backlog reportedly increased 35%, reinforcing expectations for continued demand and earnings momentum. Nordson Forecasts Fiscal 2026 Sales and EPS
• Positive Sentiment: Analyst price-target increases: Oppenheimer raised its target from $335 to $370 and upgraded its view to “outperform.” Robert W. Baird lifted its target from $328 to $351 while maintaining a “neutral” rating. DA Davidson reaffirmed its “buy” rating with a $345 target. Analysts Boost Forecasts on Nordson
• Neutral Sentiment: New medical product: Nordson MEDICAL introduced its Divert ULTRA line of ultra-high-pressure stopcocks for demanding medical applications. The launch expands the product portfolio but was not accompanied by a specific financial impact. Nordson MEDICAL Introduces Divert ULTRA
• Negative Sentiment: Insider selling and valuation: Reported insider activity showed 46 sales and no purchases over the past six months, including sizable sales by senior executives. After the rally, Nordson trades at roughly 33.6 times earnings, leaving the stock vulnerable to profit-taking if growth or guidance momentum slows.

Wall Street Analyst Weigh In

A number of analysts have commented on NDSN shares. DA Davidson restated a "buy" rating and set a $345.00 price target on shares of Nordson in a research report on Thursday. Weiss Ratings upgraded Nordson from a "hold (c+)" rating to a "buy (b-)" rating in a research report on Monday, June 29th. Robert W. Baird lifted their price target on Nordson from $328.00 to $351.00 and gave the company a "neutral" rating in a research report on Friday. KeyCorp restated a "buy" rating on shares of Nordson in a report on Thursday. Finally, BNP Paribas Exane lifted their target price on Nordson from $285.00 to $290.00 and gave the stock a "neutral" rating in a report on Friday, May 22nd. Five analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, Nordson presently has an average rating of "Moderate Buy" and an average target price of $326.57.

Nordson Company Profile

Nordson Corporation designs, manufactures and markets precision dispensing equipment and systems that apply adhesives, coatings, sealants and polymers in a broad range of industrial and medical applications. The company's portfolio spans fluid systems, curing and surface preparation technologies, vacuum and thermal management products, and advanced test and inspection solutions. Nordson's offerings serve critical manufacturing processes by delivering exacting dispensing accuracy and process control to ensure consistent product performance and high production throughput.

Nordson operates through multiple segments that cater to diverse markets including electronics, packaging, medical, energy, automotive and general industrial sectors.

Want to see what other hedge funds are holding NDSN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nordson Corporation (NASDAQ:NDSN - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source